NB can be stratified into low‐, intermediate‐, and high‐risk groups based on the demarcation of age at diagnosis, the International Neuroblastoma Staging System (INSS) stage, the tumor tissue MYCN status, the International Neuroblastoma Pathology Committee (INPC) classification, and ploidy.4 The gene discussed is MYCN; the disease is neuroblastoma.